Evolv Technologies (EVLV) Insider Neil Glat Buys 28,318 Shares
Neil Glat bought 28,318 shares of Evolv Technologies Holdings, Inc. on June 18, 2026.
Reviewed by automated data checks against the source filing. How we make and check alerts
Neil Glat bought 28,318 shares of Evolv Technologies Holdings, Inc. ($EVLV) on June 18, 2026. The trade was reported to the SEC in a Form 4 filing.
Since the trade, $EVLV is down 7.4% after 1 week, down 1.1% after 1 month and down 26.4% to date (from the $5.65 close on Jun 18, 2026).
EVLV
Evolv Technologies Holdings, Inc.
Key Points
- Neil Glat acquired 28,318 shares of Evolv Technologies on June 18, 2026, with the stock trading near $5.54 on Tuesday.
- Evolv Technologies has a market cap of $1.02 billion and faces challenges with a negative forward P/E due to unprofitability.
- Analysts maintain a strong buy consensus with a mean target price of $10.13, highlighting potential growth.
Get $EVLV trade alerts by text
We text you when insiders, Congress or big funds trade $EVLV. Free.
Not investment advice. EarningsIQ is not a registered investment adviser, and this automated Evolv Technologies Holdings, Inc. alert may contain errors. Disclosures
Neil Glat, an insider at Evolv Technologies Holdings, Inc., bought 28,318 shares of the company on June 18, 2026. The transaction was not part of a pre-planned trading program. On Tuesday, the shares of Evolv Technologies, trading under the ticker NasdaqCM:EVLV, were priced near $5.54.
Insider Buying and Selling at Evolv Technologies Holdings, Inc.
In addition to Neil Glat, several other insiders at Evolv Technologies, including Kevin Charlton, Michael Ellenbogen, Richard Shapiro, Kimberly Sheehy, and Henrik Kuhl, each purchased 28,318 shares on June 18, 2026. These transactions were also not under Rule 10b5-1 plans.
Evolv Technologies Holdings, Inc. Stock Up 10.6%
As of Tuesday, shares of Evolv Technologies Holdings, Inc. traded near $5.54. The company, with a market capitalization of approximately $1.02 billion, operates in the security and protection services industry. Despite its innovative offerings, Evolv faces profitability challenges, evidenced by a negative forward P/E ratio. The stock's 52-week range spans from $4.87 to $8.91, and it has a beta of 1.756, indicating higher volatility compared to the market. Evolv's financial health includes a current ratio of 1.207 and a quick ratio of 0.834, with a debt-to-equity ratio of 34.78.
Analysts Set New Price Targets
On June 9, 2026, TD Cowen reiterated its buy rating for Evolv Technologies with a $10 price target. The analyst consensus remains strong buy, with a mean target price of $10.13 based on four analyst opinions. This suggests a positive outlook among analysts despite the company's current financial hurdles.
About Evolv Technologies Holdings, Inc.
Evolv Technologies Holdings, Inc. develops and markets advanced security screening products. Headquartered in Waltham, Massachusetts, the company is led by CEO John Kedzierski. Evolv's technology, including the Evolv Express and eXpedite systems, is used to detect weapons in crowded areas, serving industries from healthcare and education to entertainment and government facilities. Founded in 2013, the company employs 286 people and continues to expand its reach in the security sector.
Bottom Line
Neil Glat's recent purchase of Evolv Technologies shares underscores insider confidence in the company's potential. While the company is currently not profitable, analysts maintain a strong buy consensus, indicating optimism for future growth. Investors should note that insider transactions and analyst ratings are just part of the information needed for comprehensive investment decisions.
Related Filing Alerts
Source: Neil Glat's Form 4 filing on $EVLV (Jun 18, 2026). Find the original filing: EVLV Form 4 filings on SEC EDGAR. Written by software, not financial advice. How we make alerts